{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Amyotrophic lateral sclerosis or motor neuron disease",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Riluzole",
            "via": [
              "n_inflammation",
              "n_glutamate_elevation",
              "n_mitochondrial_dysfunction"
            ],
            "to": "Amyotrophic Lateral Sclerosis",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Edaravone",
            "via": [
              "n_inflammation",
              "n_glutamate_elevation",
              "n_mitochondrial_dysfunction"
            ],
            "to": "Amyotrophic Lateral Sclerosis",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_riluzole",
          "type": "Drug",
          "label": "Riluzole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_edaravone",
          "type": "Drug",
          "label": "Edaravone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nerinetide",
          "type": "Drug",
          "label": "Nerinetide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tirasemtiv",
          "type": "Drug",
          "label": "Tirasemtiv",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nusinersen",
          "type": "Drug",
          "label": "Nusinersen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lithium",
          "type": "Drug",
          "label": "Lithium",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bicalutamide",
          "type": "Drug",
          "label": "Bicalutamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexpramipexole",
          "type": "Drug",
          "label": "Dexpramipexole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dantrolene",
          "type": "Drug",
          "label": "Dantrolene",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sodium_phenylbutyrate",
          "type": "Drug",
          "label": "Sodium phenylbutyrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amx0035",
          "type": "Drug",
          "label": "AMX0035",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cilostazol",
          "type": "Drug",
          "label": "Cilostazol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_mnd",
          "type": "Disease",
          "label": "Amyotrophic Lateral Sclerosis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_inflammation",
          "type": "Pathway",
          "label": "Inflammation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_glutamate_elevation",
          "type": "Pathway",
          "label": "Glutamate Elevation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_mitochondrial_dysfunction",
          "type": "Pathway",
          "label": "Mitochondrial Dysfunction Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_riluzole",
          "type": "Target",
          "label": "Riluzole Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_edaravone",
          "type": "Target",
          "label": "Edaravone Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_nerinetide",
          "type": "Target",
          "label": "Nerinetide Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tirasemtiv",
          "type": "Target",
          "label": "Tirasemtiv Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_nusinersen",
          "type": "Target",
          "label": "Nusinersen Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lithium",
          "type": "Target",
          "label": "Lithium Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Potential Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "Adverse Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_riluzole",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于延缓 ALS 进程"
        },
        {
          "source": "drug_edaravone",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于减缓 ALS 进展"
        },
        {
          "source": "drug_nusinersen",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "对脊髓性肌萎缩症有效，相关机制可推测对 ALS 有潜在影响"
        },
        {
          "source": "drug_lithium",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有研究表明对 ALS 可能有益"
        },
        {
          "source": "drug_dexpramipexole",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "有潜力干预 ALS 相关过程"
        },
        {
          "source": "drug_amx0035",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "新颖联合治疗显示有效性"
        },
        {
          "source": "drug_tirasemtiv",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "改善运动能力的观察性研究"
        },
        {
          "source": "drug_bicalutamide",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "理论上的影响机制存在关联"
        },
        {
          "source": "drug_sodium_phenylbutyrate",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "有可能改善 ALS 症状"
        },
        {
          "source": "drug_cilostazol",
          "target": "n_mnd",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "相关研究支持其可能性"
        },
        {
          "source": "drug_dantrolene",
          "target": "n_inflammation",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "对炎症反应的抑制作用"
        },
        {
          "source": "n_inflammation",
          "target": "n_mnd",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "炎症与 ALS 之间的已知关联"
        },
        {
          "source": "drug_nusinersen",
          "target": "n_glutamate_elevation",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "对谷氨酸水平的潜在影响"
        },
        {
          "source": "n_glutamate_elevation",
          "target": "n_mnd",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "谷氨酸极性升高被认为与 ALS 有关"
        },
        {
          "source": "drug_edaravone",
          "target": "n_mitochondrial_dysfunction",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "针对线粒体功能的已知作用"
        },
        {
          "source": "n_mitochondrial_dysfunction",
          "target": "n_mnd",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "线粒体疾病与 ALS 相关"
        },
        {
          "source": "drug_riluzole",
          "target": "n_ot_riluzole",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_edaravone",
          "target": "n_ot_edaravone",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_nerinetide",
          "target": "n_ot_nerinetide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_tirasemtiv",
          "target": "n_ot_tirasemtiv",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_nusinersen",
          "target": "n_ot_nusinersen",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_lithium",
          "target": "n_ot_lithium",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "n_ot_riluzole",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_edaravone",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_nerinetide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_tirasemtiv",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_nusinersen",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_lithium",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在的导致不良效应的路径"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_riluzole",
              "target": "n_inflammation",
              "relation": "acts_on",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "已知降低炎症反应"
            },
            {
              "source": "drug_riluzole",
              "target": "n_glutamate_elevation",
              "relation": "inhibits",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "对谷氨酸升高的影响"
            },
            {
              "source": "n_inflammation",
              "target": "n_mnd",
              "relation": "involved_in",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "炎症与 ALS 之间的已知关联"
            },
            {
              "source": "n_glutamate_elevation",
              "target": "n_mnd",
              "relation": "involved_in",
              "weight": 0.75,
              "agent": "Proponent",
              "rationale": "谷氨酸极性升高被认为与 ALS 有关"
            },
            {
              "source": "drug_riluzole",
              "target": "n_mitochondrial_dysfunction",
              "relation": "inhibits",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "已知改善线粒体功能"
            },
            {
              "source": "n_mitochondrial_dysfunction",
              "target": "n_mnd",
              "relation": "involved_in",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "线粒体疾病与 ALS 相关"
            },
            {
              "source": "drug_riluzole",
              "target": "H1",
              "relation": "supports",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "已知用于延缓 ALS 进程"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已形成 Drug→Target→Pathway→Disease 的支持路径"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": [
      "缺少对 Edaravone 的机制链接"
    ]
  }
}